RLS logo

RLS Global AB (publ) Stock Price

OM:RLS Community·SEK 35.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

RLS Share Price Performance

SEK 0
0.00 (0.00%)
SEK 0
0.00 (0.00%)
Price SEK 0

RLS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with adequate balance sheet.

4 Risks
1 Reward

RLS Global AB (publ) Key Details

SEK 1.1m

Revenue

SEK 5.1m

Cost of Revenue

-SEK 4.0m

Gross Profit

SEK 24.8m

Other Expenses

-SEK 28.8m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
Nov 23, 2023
-0.36
-374.07%
-2,677.32%
0%
View Full Analysis

About RLS

Founded
1996
Employees
9
CEO
Roland Frosing
WebsiteView website
rls.global

RLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. RLS Global AB (publ), was founded in 1996 and is based in Mölndal, Sweden.

Recent RLS News & Updates

Recent updates

No updates